Clinical Trial

Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma

Study acronym: FAPI-OSCC
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated May 28, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
In this prospective study, the investigators will use integrated PET/CT with the agent 68Ga-FAPI and conventional imaging agent 18F-FDG to explore the application value of FAP-targeted molecular imaging in the diagnosis and staging for oral cancer. This study also aims to explore the application value of FAPI imaging in evaluating treatment response for oral cancer.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05030597
Lead Sponsor Zhongnan Hospital
Conditions PET/CT, FAPI, Oral Cancer
Enrollment 100 participants
Start Date 2021-09-15
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-28